FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Particle FOXO4 DRI (Proxofim) is a synthetic peptide with a retro inverted structure, developed as a modified version of the natural FOXO4 protein. Scientific interest in this compound is growing, especially within FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs